These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 33932127)
1. TNF-α/NF-κB signaling epigenetically represses PSD4 transcription to promote alcohol-related hepatocellular carcinoma progression. Shi J; Song S; Li S; Zhang K; Lan Y; Li Y Cancer Med; 2021 May; 10(10):3346-3357. PubMed ID: 33932127 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma. Sun QM; Hu B; Fu PY; Tang WG; Zhang X; Zhan H; Sun C; He YF; Song K; Xiao YS; Sun J; Xu Y; Zhou J; Fan J Carcinogenesis; 2018 Dec; 39(12):1438-1446. PubMed ID: 30169594 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65. Liu ZC; Ning F; Wang HF; Chen DY; Cai YN; Sheng HY; Lash GE; Liu L; Du J Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2568-2582. PubMed ID: 28844984 [TBL] [Abstract][Full Text] [Related]
4. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation. Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation. Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422 [TBL] [Abstract][Full Text] [Related]
6. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494 [TBL] [Abstract][Full Text] [Related]
8. DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma. Zhu B; Chen JJ; Feng Y; Yang JL; Huang H; Chung WY; Hu YL; Xue WJ J Exp Clin Cancer Res; 2021 Nov; 40(1):352. PubMed ID: 34749775 [TBL] [Abstract][Full Text] [Related]
9. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal. Zhang J; Zhang DL; Jiao XL; Dong Q Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232 [TBL] [Abstract][Full Text] [Related]
10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862 [TBL] [Abstract][Full Text] [Related]
12. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway. Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin. Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
16. p28(GANK) associates with p300 to attenuate the acetylation of RelA. Ren YB; Luo T; Li J; Fu J; Wang Q; Cao GW; Chen Y; Wang HY Mol Carcinog; 2015 Dec; 54(12):1626-35. PubMed ID: 25400040 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-κB pathway. Liang DY; Sha S; Yi Q; Shi J; Chen Y; Hou Y; Chang Q Cell Signal; 2019 Oct; 62():109346. PubMed ID: 31229617 [TBL] [Abstract][Full Text] [Related]
18. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma. Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2. Fan H; Zhang H; Pascuzzi PE; Andrisani O Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293 [TBL] [Abstract][Full Text] [Related]
20. Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma. Wang F; Yang JL; Yu KK; Xu M; Xu YZ; Chen L; Lu YM; Fang HS; Wang XY; Hu ZQ; Li FF; Kan L; Luo J; Wang SY Mol Cancer; 2015 Jan; 14(1):10. PubMed ID: 25622857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]